GH Research PLC (GHRS) to speak at RBC Psychedelics Symposium panel
Rhea-AI Filing Summary
GH Research PLC, an Ireland-based biopharmaceutical company, reported that it will take part in a panel discussion at the RBC Capital Markets Psychedelics Symposium: A Trip Into The Future of Mental Health. The event is scheduled to be held virtually on January 22, 2026.
The company will be represented in this regulatory report by Julie Ryan, Vice President, Finance, who signed the submission on behalf of GH Research PLC. The filing is primarily informational and highlights the company’s participation in an industry-focused conference rather than providing financial or operating results.
Positive
- None.
Negative
- None.
FAQ
What event is GHRS (GH Research PLC) participating in?
GH Research PLC will participate in a panel discussion during the RBC Capital Markets Psychedelics Symposium: A Trip Into The Future of Mental Health.
When will GH Research PLC take part in the RBC Capital Markets Psychedelics Symposium?
The symposium, including the panel discussion featuring GH Research PLC, is scheduled to take place virtually on January 22, 2026.
Is the GH Research PLC appearance at the RBC Capital Markets Psychedelics Symposium in-person or virtual?
The company’s participation in the RBC Capital Markets Psychedelics Symposium is described as virtual.
Who signed the January 2026 GHRS Form 6-K report?
The report was signed on behalf of GH Research PLC by Julie Ryan, who is identified as the company’s Vice President, Finance.
Does this GHRS Form 6-K include financial results or major transactions?
No financial results or major transactions are described; the report focuses on GH Research PLC’s participation in an industry panel discussion.
Where is GH Research PLC headquartered?
GH Research PLC’s principal executive office is located at Joshua Dawson House, Dawson Street, Dublin 2, D02 RY95, Ireland.